General
Preferred name
HALOXON
Synonyms
Haloxone ()
P&D ID
PD014443
CAS
321-55-1
53196-70-6
Tags
available
drug
Approved by
FDA
Drug Status
approved
vet_approved
investigational
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Haloxon is an anti-parasitic agent. Haloxon can be used for the research of infections of Parascaris equorum, Oxyuris equi and Strongylus vulgaris. Haloxon also can be used in control of ascarids and hookworms in domesticated animals in combination with Bidimazium[1][2].
DESCRIPTION Haloxon is an organophosphorus anthelmintic once used against nematodes of the abomasum and small intestine in ruminants. (BOC Sciences Bioactive Compounds)
Compound Sets
8
BOC Sciences Bioactive Compounds
haloxon-cas-321-55-1-item-84-179048
ChEMBL Drugs
CHEMBL1897362
DrugBank
DB11419
DrugBank Approved Drugs
DB11419
DrugCentral
5554
MedChem Express Bioactive Compound Library
HY-17532
NPC Screening Collection
ReFrame library
External IDs
21
Properties
(calculated by RDKit )
Molecular Weight
413.96
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
0
Rotatable Bonds
8
Ring Count
2
Aromatic Ring Count
2
cLogP
4.75
TPSA
74.97
Fraction CSP3
0.36
Chiral centers
0.0
Largest ring
6.0
QED
0.35
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Parasite
Pathway
Anti-infection
Source data